<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CE43EBFA-3FC9-44BC-B6FF-001F11664C46"><gtr:id>CE43EBFA-3FC9-44BC-B6FF-001F11664C46</gtr:id><gtr:name>Aarhus University</gtr:name><gtr:address><gtr:line1>Nordre Ringgade 1</gtr:line1><gtr:line4>Aarhus C</gtr:line4><gtr:line5>DK-8000</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/414D6FAE-63F9-4154-9BD8-36BDF24C1126"><gtr:id>414D6FAE-63F9-4154-9BD8-36BDF24C1126</gtr:id><gtr:name>Kadmon Corporation</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AD4854E1-71AF-4687-93A9-5F05968D34DB"><gtr:id>AD4854E1-71AF-4687-93A9-5F05968D34DB</gtr:id><gtr:name>University of Pisa</gtr:name><gtr:address><gtr:line1>University of Pisa</gtr:line1><gtr:line2>Lungarno Pacinotti 43</gtr:line2><gtr:line4>Pisa</gtr:line4><gtr:postCode>I 56126</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9AEE9BF3-C281-47A7-BF7F-9B74BEA8B9B0"><gtr:id>9AEE9BF3-C281-47A7-BF7F-9B74BEA8B9B0</gtr:id><gtr:name>Dyax</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3365522A-B8C4-48F1-9A44-6639D10D9E65"><gtr:id>3365522A-B8C4-48F1-9A44-6639D10D9E65</gtr:id><gtr:name>Bicycle Therapeutics</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Kennedy Institute</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CE43EBFA-3FC9-44BC-B6FF-001F11664C46"><gtr:id>CE43EBFA-3FC9-44BC-B6FF-001F11664C46</gtr:id><gtr:name>Aarhus University</gtr:name><gtr:address><gtr:line1>Nordre Ringgade 1</gtr:line1><gtr:line4>Aarhus C</gtr:line4><gtr:line5>DK-8000</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/414D6FAE-63F9-4154-9BD8-36BDF24C1126"><gtr:id>414D6FAE-63F9-4154-9BD8-36BDF24C1126</gtr:id><gtr:name>Kadmon Corporation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AD4854E1-71AF-4687-93A9-5F05968D34DB"><gtr:id>AD4854E1-71AF-4687-93A9-5F05968D34DB</gtr:id><gtr:name>University of Pisa</gtr:name><gtr:address><gtr:line1>University of Pisa</gtr:line1><gtr:line2>Lungarno Pacinotti 43</gtr:line2><gtr:line4>Pisa</gtr:line4><gtr:postCode>I 56126</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9AEE9BF3-C281-47A7-BF7F-9B74BEA8B9B0"><gtr:id>9AEE9BF3-C281-47A7-BF7F-9B74BEA8B9B0</gtr:id><gtr:name>Dyax</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3365522A-B8C4-48F1-9A44-6639D10D9E65"><gtr:id>3365522A-B8C4-48F1-9A44-6639D10D9E65</gtr:id><gtr:name>Bicycle Therapeutics</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/461F9CFF-9C4C-49B9-9580-B133C0968A27"><gtr:id>461F9CFF-9C4C-49B9-9580-B133C0968A27</gtr:id><gtr:firstName>Yoshifumi</gtr:firstName><gtr:surname>Itoh</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802007"><gtr:id>F7501638-B2E0-440C-A867-D3F69F2D0B4B</gtr:id><gtr:title>IDENTIFICATION OF MEMBRANE-TYPE 1 MATRIX METALLOPROTEINASE AS A NOVEL THERAPEUTIC TARGET OF RHEUMATOID ARTHRITIS</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802007</gtr:grantReference><gtr:abstractText>Rheumatoid arthritis (RA) is a systemic autoimmune disease whose key pathological features is destruction of joint tissues including cartilage. Our recent data indicated that a cell membrane-anchored protein degrading enzyme termed, MT1-MMP, plays an essential role in cartilage erosion in RA. We hypothesize that specific inhibition of MT1-MMP can be a potential RA treatment. We propose to address this by assessing the effect of MT1-MMP inhibition in RA progression in a collagen-induced arthritis (CIA) in transgenic mice that express a dominant negative inhibitor of MT1-MMP. We will also analyze the effect of a MT1-MMP-specific inhibitory antibody in mice with CIA. Completing the proposed work would establish MT1-MMP as a novel therapeutic target of RA treatment, which may lead into development of novel RA therapy in the future.</gtr:abstractText><gtr:technicalSummary>Rheumatoid arthritis (RA) is a systemic autoimmune disease whose key pathological features is destruction of joint tissues by inflamed synovial pannus tissue leading to a loss of joint function. We have recently discovered that one of the membrane-anchored matrix metalloproteinases (MT-MMPs), MT1-MMP, plays an essential role in promoting pannus invasion into cartilage in RA. MT1-MMP is highly expressed in the synovial cells forming a cartilage invasion front and inhibition of MT1-MMP effectively abrogates synovial cell invasion into cartilage matrix. MT1-MMP has also been shown to be an important molecule in the process of angiogenesis, as well as monocyte endothelial transmigration, both of which are essential steps in RA progression. Therefore, we hypothesize that specific inhibition of MT1-MMP can be a potential therapeutic intervention for RA treatment. To test the effect of MT1-MMP inhibition in RA progression, we have developed useful tools: transgenic mice that express a dominant negative form of MT1-MMP in fibroblasts and an MT1-MMP-specific inhibitory antibody. We will challenge the transgenic mice with collagen-induced arthritis (CIA) to examine the role of MT1-MMP in synovial fibroblasts during development of arthritis in vivo. We will also administer the MT1-MMP inhibitory antibody to mice with CIA in order to examine the role of MT1-MMP in broader cell populations during RA development, including endothelial cells and macrophages. Completing the proposed work would establish MT1-MMP as a novel therapeutic target of RA treatment, which may lead into development of novel RA therapy in the future.</gtr:technicalSummary><gtr:fund><gtr:end>2012-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>813914</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kadmon Corporation</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Kadmon</gtr:description><gtr:id>B75EBBD3-4DD8-47A1-8CA7-0E5D576F3FA2</gtr:id><gtr:impact>Kadmon has just sent us 100 mg of DX-2400 they inherited from Dyax.</gtr:impact><gtr:outcomeId>537f35dfd9ea61.67090492-1</gtr:outcomeId><gtr:partnerContribution>Kadmon provides us DX-2400 for our research now.</gtr:partnerContribution><gtr:piContribution>Kadmon made exclusive deal with Dyax to develop DX-2400, MT1-MMP highly selective antibody inhibitor. As Dyax has been supplying DX-2400, I initiated forming a contract with Kadmon. It is almost end stage to finalise MTA.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>DDR-selective RTK inhibitors</gtr:description><gtr:id>95CF6F29-EE9E-40B5-A140-F22DF76223B8</gtr:id><gtr:impact>We obtained positive data and submitted programme grant to Arthritis Research UK.</gtr:impact><gtr:outcomeId>55535e34e8b990.93453787-1</gtr:outcomeId><gtr:partnerContribution>Dr. Nathanael Gray provides us DDR-selective inhibitors.</gtr:partnerContribution><gtr:piContribution>We examine the effect of DDR-selective inhibitors in our assay system.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Aarhus University</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>Kenneth Alr&amp;oslash; B&amp;oslash;tkj&amp;aelig;r</gtr:description><gtr:id>5CFFC1F1-C839-4E9E-A1F5-F38829AE2335</gtr:id><gtr:impact>Kenneth has screened MT1-MMP inhibitors using phage display antibody library in University of Cambridge. He successfully obtained two strong candidates and optimised. They are single chain Fv-Fc fusion protein, and have very high affinity with high selectivity. He is now scaling up the production of these inhibitors to use for animal studies and cell culture models.</gtr:impact><gtr:outcomeId>53846d8f134f40.55519783-1</gtr:outcomeId><gtr:partnerContribution>He has provided us two inhibitors for cell culture studies.</gtr:partnerContribution><gtr:piContribution>Kenneth provides us antibody based highly selective MT1-MMP inhibitors. I was one of the collaborators to develop these inhibitors.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Kennedy Institute of Rheumatology</gtr:department><gtr:description>Dr. Richard Williams</gtr:description><gtr:id>257A7E0C-C48B-494E-98DF-51863D6C2409</gtr:id><gtr:impact>Paper is in preparation</gtr:impact><gtr:outcomeId>EyiE1DgfXqw-1</gtr:outcomeId><gtr:partnerContribution>Dr. Williams provides us his expertise on the mouse model of arthritis.</gtr:partnerContribution><gtr:piContribution>This is a direct collaboration on collagen-induced arthritis mouse model. We test the role of MT1-MMP in arthritis development.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bicycle Therapeutics</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MT1-MMP inhibitor development</gtr:description><gtr:id>84237BFB-63C2-4EFB-AB98-7A42DB18259F</gtr:id><gtr:impact>we have now some lead and backup compounds that binds to hemopexin domain. They are now screening to identify the one which binds to catalytic domain. We are now in process of testing the compounds in our biological assays.</gtr:impact><gtr:outcomeId>Bdv6nsZzQBE-1</gtr:outcomeId><gtr:partnerContribution>They have developed candidate conpounds and we are now testing.</gtr:partnerContribution><gtr:piContribution>We are seeking to develop selective MT1-MMP inhibitors and made a collaboration with Bicycle therapeutics to develop such inhibitors. Our role is to screen the inibitors.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Dyax</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Dyax</gtr:description><gtr:id>4E7C3B1A-C151-4F25-9EF7-247F8E40ADE9</gtr:id><gtr:impact>As it is, it is still active, but getting uncertain as the company has changed their direction. They layed off the team I was working with.</gtr:impact><gtr:outcomeId>Ri8oGfWTYu4-1</gtr:outcomeId><gtr:partnerContribution>Dyax provided DX-2400</gtr:partnerContribution><gtr:piContribution>Dyax provided us DX-2400 to test it on collagen induced arthritis model, and discovered it is effective.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MT1-MMP inhibitory antibody/Prof Gillian Murphy</gtr:description><gtr:id>043B189F-2136-43E8-9B17-15F95ABCD924</gtr:id><gtr:impact>This collaboration resulted MRC grant award in 2009.</gtr:impact><gtr:outcomeId>55535831bc8134.29850198-1</gtr:outcomeId><gtr:partnerContribution>Professor Gillian Murphy at university of Cambridge provides us highly selective MT1-MMP inhibitory antibodies.</gtr:partnerContribution><gtr:piContribution>We examine the efficacy of MT1-MMP inhibitory antibodies for mouse model of arthritis as well as in vitro cell based assay systems.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pisa</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Small molecule MMP/ADAM inhibitors</gtr:description><gtr:id>E4CC743D-4750-46F8-9117-111E0253EA1C</gtr:id><gtr:impact>This collaboration resulted award of ERASMUS grant to the PhD student in the University of PISA.</gtr:impact><gtr:outcomeId>5553592e749a41.22573415-1</gtr:outcomeId><gtr:partnerContribution>Prof. Armando Rossello provides us small molecule MMP inhibitors.</gtr:partnerContribution><gtr:piContribution>We test small molecule MMP inhibitor in mouse model of arthritis and in vitro assays.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Euroscicon meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0DDB34BE-020C-497E-9C74-AD835D841264</gtr:id><gtr:impact>Discussion workshop: Live Cell Imaging 17/06/2011 
EuroSciCon
Title: Imaging Cellular Invasion: Role of the Cell Surface Collagen Degrading Enzyme
Author: Yoshifumi Itoh
I have discussed how we perform cellular invasion.

There are about 50 people attended.

Many discussions were made how we perform our invasion analyses. There are PhD students and Postdocs from achademics and some from bio-tech companies.</gtr:impact><gtr:outcomeId>e99UAGVomPx</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>An invited speaker for International Symposium of Matrix Biology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FF99EE5F-B89F-4F3B-A921-E6BB7FB068C9</gtr:id><gtr:impact>The talk provoked active discussion.

It may result in new collaborative project.</gtr:impact><gtr:outcomeId>55535ab12e4946.21793003</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker of XVII meeting of the Brazilian Society for Cell Biology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5D89CC11-B188-4ED8-9E9C-1542326D547E</gtr:id><gtr:impact>I received several questions from audiences, and had a many other questions afterwards.

Many people gave me a very positive feed backs and had many questions afterwards with potential collaborations.</gtr:impact><gtr:outcomeId>546488e7a74164.96082386</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.interevent.com.br/evento/sbbc2014</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>An invited speaker for MMP Gordon Research Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>77480FA1-6BCE-43ED-B048-27B3887DF9EC</gtr:id><gtr:impact>I took a role of session chair and gave a talk as an invited speaker.around 95 scientists from all over the world have attended the meeting. My presentation provoked active discussion in the meeting, and I was appraised by the audience.</gtr:impact><gtr:outcomeId>56d59d236864f0.09415255</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.grc.org/programs.aspx?id=12358</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting presentation at Winterschool of proteolytic enzymes and their inhibitors</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F08F4329-971E-4132-AF6F-D10B86889052</gtr:id><gtr:impact>Winter school of Proteiolytic enzymes and their inhibitors
Title: MT1-MMP activity is modified by other MT-MMPs
Authors: Kazuyo Kaneko and Yoshifumi Itoh

About 100 PhD and MSc students attended.


Many questions were raised.</gtr:impact><gtr:outcomeId>cf9MSWNwwen</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Vice chancellors meeting at Oxford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8A2C053F-6B88-4E95-BB8F-2B8D42129BA4</gtr:id><gtr:impact>All high gear University of Oxford achademics have presented in this conference. 
&amp;quot;Vice Chancellor's Symposium: Inflammatory mechanisms and inflammatory diseases&amp;quot;
Title: Cell trafficking: Role of cell surface metalloproteinase, MT1-MMP
Authors: Yoshifumi Itoh

I received may feed back indicating their interests to the works.</gtr:impact><gtr:outcomeId>ABVNziFtibd</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker at Proteoglycan 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6394EFE8-BD43-47B3-A7BF-176E75AD3120</gtr:id><gtr:impact>Over 150 attendees from different countries attended. I have given a 25 min seminar. I had good discussions.

I received good responses from different people.</gtr:impact><gtr:outcomeId>G1qeS4Cfhns</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.proteoglycans2013.com</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker to 46th Sandbjerg Meeting on Membrane Transport</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9DFC3FEB-9B58-4999-99ED-A04877B3EC3D</gtr:id><gtr:impact>46th Sandbjerg Meeting on Membrane Transport
Date: Monday May 12th, 1.00 pm - Wednesday, May 14th, 2.00 pm 2014
Place Sandbjerg Estate, S&amp;oslash;nderborg, Denmark
Topics:
1. Regulation and roles of proteases at the plasma membrane I 
2. Regulation and roles of proteases at the plasma membrane II 
3. How lipids cross cellular membranes 
4. Free communications in membrane transport 
My talk of title was: Spatiotemporal regulation of MT1-MMP determines cellular invasion.

Attending this meeting, I am initiating two collaborations with University of Copenhagen. The response of the talk by the audience was excellent.</gtr:impact><gtr:outcomeId>537f38f6d2c4c4.60196143</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://membranes.au.dk/sandbjerg-meeting/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MMP gordon research conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2881995F-8293-476A-A588-B300EA3FF72E</gtr:id><gtr:impact>170 academics have attended the meeting.

The poster was selected as an oral presentation.</gtr:impact><gtr:outcomeId>BctXpv8uzww</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited keynote lecture for annual meeting of Japan Connective Tissue Society</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>55272E54-B7AD-4601-9705-6427211CF639</gtr:id><gtr:impact>My talk provoked active discussion.

The talk disseminated our findings to academic researchers working in the field of Matrix Biology in Japan.</gtr:impact><gtr:outcomeId>55535cbd757d40.10130264</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.jsctr.org/science_rally.htm</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>An invited speaker for Symposium for &quot;Future of Extracellular Matrix Research&quot;</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A4CB854E-909F-49B4-A3B9-C1A59F8B6702</gtr:id><gtr:impact>There were over 80 scientists from Japan as audiences. The symposium was dedicated to Dr. Akira Ito's retirement.
&amp;quot;Future of Extracellular Matrix Research&amp;quot; (Tokyo, Japan, 22 March 2014)
Title of the talk: MT1-MMP: A Molecular Target in Rheumatoid Arthritis


I received over 10 positive questions/comments from audiences.</gtr:impact><gtr:outcomeId>537b4d60b091a8.10577305</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>An Invited speaker for Matrix Biology Europe meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1E5EF548-0E1A-461F-AB82-691C8C0CE552</gtr:id><gtr:impact>I was invited speaker in one of the session. I presented our recent study on role of MT1-MMP in rheumatoid arthritis in front of around 100 people who are international academic scientists and graduate students. I received several questions in discussion and after the session as well.</gtr:impact><gtr:outcomeId>58c66df572e753.95041906</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.mbe2016.upatras.gr</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>An invited Keynote speaker for ShRImP Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>51E8DA40-CD9A-4371-BDB1-3BCE71E6BFB5</gtr:id><gtr:impact>approximately 30 people attended from Germany and Italy, who are academics, medical doctors and post graduate students. Upon talk was given, active discussion took place. With this, I have engaged collaborations with German group from TUM.</gtr:impact><gtr:outcomeId>56d59c078dca33.77265117</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MMP Gordon Research conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7A03FE50-C750-44CA-B98B-458A57150D28</gtr:id><gtr:impact>MMP Gordon Research Conference (Rhode Island, USA, August 2011)
Title: Invadopodia or not invadopodia? MT1-MMP localization to the substrate attachment site regulates cellular invasion.
Authors: Yoshifumi Itoh
I have presented our recent data how MT1-MMP is localized at invasion front of invading cells.

There aremany discussions made on this topics.</gtr:impact><gtr:outcomeId>AwkhGoYaTWp</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>223407</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Autofluorescence lifetime metrology for label-free readouts of heart disease and arthritis</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/I02770X/1</gtr:fundingRef><gtr:id>6A522CB2-EC35-4292-8DE3-5B8D7A9A5061</gtr:id><gtr:outcomeId>Bk8TjdoHs1S</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The role of cell surface metalloproteinases in the development of rheumatoid arthritis</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:fundingRef>19797</gtr:fundingRef><gtr:id>B89FE51F-6890-4976-B038-F0D6C5805343</gtr:id><gtr:outcomeId>NTajvaqyekF</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Dyax made DX-2400 which is a selective MT1-MMP inhibitory antibody. We collaborated with Dyax and tested efficacy of DX-2400 in collagen induced arthritis model. As our original antooibody inhibitor development was much delayed, we employed DX-2400 to carry our our projects. We discovered DX-2400 to suppress arthritis development. Especially it has significant effect when it si co-administrated with anti- TNF blockade.</gtr:description><gtr:id>B2AFC504-FF11-4492-A2AE-B177DE93B8BB</gtr:id><gtr:impact>Dyax licensed DX-2400 to Kadon, and I am now dealing with Kadmon to test DX-2400 further.</gtr:impact><gtr:outcomeId>H1jpnzg4Guf</gtr:outcomeId><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>On hold</gtr:status><gtr:title>DX-2400</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2014</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>We are still screening the compounds in collaboration with Bicycle therapeutics.</gtr:description><gtr:id>A7813848-4CA9-432E-824D-E7AB0F83DE9B</gtr:id><gtr:impact>It is still not known yet.</gtr:impact><gtr:outcomeId>Q1WBG9kynqt</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>MT1-MMP inhibitors</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2014</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This is a recombinant DDR2-Fc fusion protein.</gtr:description><gtr:id>FE27C95B-5052-4C7F-A329-CC9E3FABBE9A</gtr:id><gtr:impact>This is very useful to study interaction of DDR2 with collagen.</gtr:impact><gtr:outcomeId>oRp34GCdvGb</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Soluble DDR2-Fc fusion protein</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Assay method to examine cartilage can stimulate DDR2 by fibroblasts</gtr:description><gtr:id>4CD68760-DB19-4B63-B278-37B6A9479353</gtr:id><gtr:impact>Bovine nasal cartilage is sliced into 2 mm thickness and punched with biopsy punch with 4 mm diameter. The cartilage was placed in the 48 well plate and culture the cell atop of the tissue for 6h. Cartilage with cells are then transferred to new 48 well to remove cells that did not attached. Culture another 40h to see the down stream event of DDR2 activation.</gtr:impact><gtr:outcomeId>537b7efd0d47a0.74952493</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Method to activate DDRs with cartilage matrix</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This inhibitor was developed by collaboration with Prof Gillian Murphy at University of Cambridge. Our involvement was to screen the candidate inhibitors. This is an biologic inhibitor screened by phage-display library. It inhibits MT1-MMP-depedent cellular invasion and ECM degradation.</gtr:description><gtr:id>E8DD6BAA-01ED-4288-ABA3-C8F769180090</gtr:id><gtr:impact>This is highly selective biological inhibitor.</gtr:impact><gtr:outcomeId>56d59df09798e8.00434718</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MT1-MMP highly selective inhibitor, E2_C6</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BD6BC566-2F7F-462D-91D1-2141289FB29A</gtr:id><gtr:title>Basal localization of MT1-MMP is essential for epithelial cell morphogenesis in 3D collagen matrix.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbd565828a07d6ece5bee2526150ec54"><gtr:id>bbd565828a07d6ece5bee2526150ec54</gtr:id><gtr:otherNames>Weaver SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>pm_14057_27_24463815</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2045F194-0858-4673-839C-8A3AC30566BD</gtr:id><gtr:title>Metalloproteinases in Rheumatoid Arthritis: Potential Therapeutic Targets to Improve Current Therapies.</gtr:title><gtr:parentPublicationTitle>Progress in molecular biology and translational science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec595a8aeab852b1251d93d02d7bf9a9"><gtr:id>ec595a8aeab852b1251d93d02d7bf9a9</gtr:id><gtr:otherNames>Itoh Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1877-1173</gtr:issn><gtr:outcomeId>592882ba562252.58281225</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2872F19F-C068-49C2-8983-24F87830D985</gtr:id><gtr:title>ADAM10 controls collagen signaling and cell migration on collagen by shedding the ectodomain of discoidin domain receptor 1 (DDR1).</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4320676f9d24dddd4d4d68c6b477942b"><gtr:id>4320676f9d24dddd4d4d68c6b477942b</gtr:id><gtr:otherNames>Shitomi Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn><gtr:outcomeId>555355a33180d8.04523062</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CADAA81-78B3-471E-BFD4-06397F3831A7</gtr:id><gtr:title>Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivo.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52ece1a59ec922b534d10e54dd8a58c8"><gtr:id>52ece1a59ec922b534d10e54dd8a58c8</gtr:id><gtr:otherNames>Botkjaer KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>573ae02bdc24b8.17008376</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F33C845-6415-4040-A9A8-84773443C6D5</gtr:id><gtr:title>Invasive potential of human rheumatoid tenosynovial cells is in part MT1-MMP dependent.</gtr:title><gtr:parentPublicationTitle>The Journal of hand surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7460b8b4f85e4e7ea39f32b6711eb30"><gtr:id>a7460b8b4f85e4e7ea39f32b6711eb30</gtr:id><gtr:otherNames>Jain A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0363-5023</gtr:issn><gtr:outcomeId>pm_14057_17_19596176</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E8D38F9-C676-4D61-9AB7-BE86E2E71BBC</gtr:id><gtr:title>Metalloproteinases: potential therapeutic targets for rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>Endocrine, metabolic &amp; immune disorders drug targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec595a8aeab852b1251d93d02d7bf9a9"><gtr:id>ec595a8aeab852b1251d93d02d7bf9a9</gtr:id><gtr:otherNames>Itoh Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1871-5303</gtr:issn><gtr:outcomeId>56d592edad0167.54323339</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80FEF215-126E-4388-BCE6-B03243164A66</gtr:id><gtr:title>Discoidin domain receptor 2 mediates collagen-induced activation of membrane-type 1 matrix metalloproteinase in human fibroblasts.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/592d8add3c2e63d6cceb495753857238"><gtr:id>592d8add3c2e63d6cceb495753857238</gtr:id><gtr:otherNames>Majkowska I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>58c66a36efabf0.20013382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3B819E4-8F60-4C84-BC12-A4B9255CB560</gtr:id><gtr:title>Metalloproteinase binding proteins: WO2009097397.</gtr:title><gtr:parentPublicationTitle>Expert opinion on therapeutic patents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec595a8aeab852b1251d93d02d7bf9a9"><gtr:id>ec595a8aeab852b1251d93d02d7bf9a9</gtr:id><gtr:otherNames>Itoh Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1354-3776</gtr:issn><gtr:outcomeId>pm_14057_27_20486866</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D2506DA-24FC-4D8F-A297-4FBF1C0E1DEC</gtr:id><gtr:title>Dimerization of MT1-MMP during cellular invasion detected by fluorescence resonance energy transfer.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec595a8aeab852b1251d93d02d7bf9a9"><gtr:id>ec595a8aeab852b1251d93d02d7bf9a9</gtr:id><gtr:otherNames>Itoh Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_14057_27_21846327</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3D3610A-E76D-499F-9C35-26D7788ACFF1</gtr:id><gtr:title>Characterization of the interface between normal and transformed epithelial cells.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/afec186a62568988d8271c080104da27"><gtr:id>afec186a62568988d8271c080104da27</gtr:id><gtr:otherNames>Hogan C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>pm_14057_17_19287376</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BE4D2E3-B755-4665-B7AF-BDA4B8EE8B4D</gtr:id><gtr:title>Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6c5b295fa9e4d4a95b9130eda6e9ab3"><gtr:id>f6c5b295fa9e4d4a95b9130eda6e9ab3</gtr:id><gtr:otherNames>Miller MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>pm_14057_17_19248098</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41A05F01-0D78-426B-BB03-ABFF7FF3DBFB</gtr:id><gtr:title>Membrane-type matrix metalloproteinases: Their functions and regulations.</gtr:title><gtr:parentPublicationTitle>Matrix biology : journal of the International Society for Matrix Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec595a8aeab852b1251d93d02d7bf9a9"><gtr:id>ec595a8aeab852b1251d93d02d7bf9a9</gtr:id><gtr:otherNames>Itoh Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0945-053X</gtr:issn><gtr:outcomeId>555355f451fbf7.44885015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C0AFD04-54A7-42F6-A662-B97DFFAE2D99</gtr:id><gtr:title>MT-LOOP-dependent localization of membrane type I matrix metalloproteinase (MT1-MMP) to the cell adhesion complexes promotes cancer cell invasion.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e09df0f1d6b3e72242091166a3b6f741"><gtr:id>e09df0f1d6b3e72242091166a3b6f741</gtr:id><gtr:otherNames>Woskowicz AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_14057_27_24165131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>707537E1-7FB5-43CB-8FA7-F98E533EC870</gtr:id><gtr:title>Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade.</gtr:title><gtr:parentPublicationTitle>Arthritis &amp; rheumatology (Hoboken, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/226e0773d32e2fb0d383b6cc66ff2d45"><gtr:id>226e0773d32e2fb0d383b6cc66ff2d45</gtr:id><gtr:otherNames>Kaneko K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2326-5191</gtr:issn><gtr:outcomeId>56d592ed7bdb31.54946773</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFE9DEB1-D0C3-4407-9742-A2B7B43DCDF2</gtr:id><gtr:title>Inhibition of Shedding of Low-Density Lipoprotein Receptor-Related Protein 1 Reverses Cartilage Matrix Degradation in Osteoarthritis.</gtr:title><gtr:parentPublicationTitle>Arthritis &amp; rheumatology (Hoboken, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c4c30911b9e6624ed3f54e79b6d8300"><gtr:id>4c4c30911b9e6624ed3f54e79b6d8300</gtr:id><gtr:otherNames>Yamamoto K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2326-5191</gtr:issn><gtr:outcomeId>58c66ab21d7708.05266761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2928360F-3CD6-4097-845D-C12E5B6C256E</gtr:id><gtr:title>Highly sensitive and adaptable fluorescence-quenched pair discloses the substrate specificity profiles in diverse protease families.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e58cb9aaaff9f6e7b68029ec86e8f15d"><gtr:id>e58cb9aaaff9f6e7b68029ec86e8f15d</gtr:id><gtr:otherNames>Poreba M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c66aebe4f683.47189519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A757F226-7515-4AFF-8846-35288A9EB697</gtr:id><gtr:title>Analysis of MMP-dependent cell migration and invasion.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff30d1de11e932e87beb97e03c9685a9"><gtr:id>ff30d1de11e932e87beb97e03c9685a9</gtr:id><gtr:otherNames>Palmisano R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_14057_27_20135295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5D5E419-BEE9-4980-B82F-8DE618D8EDED</gtr:id><gtr:title>Detection of cartilage matrix degradation by autofluorescence lifetime.</gtr:title><gtr:parentPublicationTitle>Matrix biology : journal of the International Society for Matrix Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d47f8cf7f884aeae0e20fdf277be33d"><gtr:id>1d47f8cf7f884aeae0e20fdf277be33d</gtr:id><gtr:otherNames>Manning HB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0945-053X</gtr:issn><gtr:outcomeId>pm_14057_27_23266527</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1861CAA-3E7D-4FDD-AA92-8C299AE0A409</gtr:id><gtr:title>The dimer interface of the membrane type 1 matrix metalloproteinase hemopexin domain: crystal structure and biological functions.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d4687466a3ff2df24e2b90e6ec119c2"><gtr:id>1d4687466a3ff2df24e2b90e6ec119c2</gtr:id><gtr:otherNames>Tochowicz A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_14057_27_21193411</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF149DC9-29B8-4101-A0B8-75F56228F295</gtr:id><gtr:title>Proteoglycans in health and disease: the multiple roles of syndecan shedding.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c303644585fd04739a53073e81365161"><gtr:id>c303644585fd04739a53073e81365161</gtr:id><gtr:otherNames>Manon-Jensen T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>pm_14057_27_20840585</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802007</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>